...
首页> 外文期刊>Analytical cellular pathology: the journal of the European Society for Analytical Cellular Pathology >Evaluation of c-erbB-2 overexpression and Her-2eu gene copy number heterogeneity in Barrett's adenocarcinoma.
【24h】

Evaluation of c-erbB-2 overexpression and Her-2eu gene copy number heterogeneity in Barrett's adenocarcinoma.

机译:巴雷特腺癌中c-erbB-2过表达和Her-2 / neu基因拷贝数异质性的评估。

获取原文
获取原文并翻译 | 示例
           

摘要

Amplification of the Her-2eu gene is accompanied by overexpression of its cell surface receptor product, c-erbB-2 protein. To investigate the degree of intratumoural heterogeneity we applied immunohistochemistry in primary Barrett's adenocarcinoma (BCA) (n = 6) and dysplasia adjacent to the carcinoma (n = 4). In addition, fluorescence in situ hybridisation (FISH) was performed in primary BCA (n = 5) and dysplastic areas (n = 4). For an objective evaluation digital image analysis and laser scanning microscopy were used. Five of six BCA showed a marked intratumoral heterogeneous staining pattern ranging from areas in which the tumour cells were negative or faintly positive to tumour areas with a strong staining of the entire membrane. Among the two dysplastic areas also a heterogeneous staining pattern was observed. FISH analysis revealed marked heterogeneity of intratumoral gene copy number changes in all BCA showing populations with different fractions of cells with polysomy, low level amplification and high level amplification. One dysplasia showed a minor population with Her-2eu signal clusters. In conclusion, we observed marked intratumoural heterogeneity of c-erbB-2 protein overexpression and Her-2eu gene copy number in the majority of the primary BCA analyzed. Digital image analysis and laser scanning microscopy were helpful in quantifying the variations in protein expression and DNA copy number in individual tumour cells. The observed heterogeneity could hamper the exact diagnostic determination of the c-erbB-2 status in small biopsies and possibly influence the effectiveness of a potential c-erbB-2 targeting therapy. Figures on http://www.esacp.org/acp/2000/20-1/walch.htm+ ++.
机译:Her-2 / neu基因的扩增伴随有其细胞表面受体产物c-erbB-2蛋白的过表达。为了研究肿瘤内异质性的程度,我们在原发性巴雷特氏腺癌(BCA)(n = 6)和癌旁不典型增生(n = 4)中应用了免疫组织化学。此外,在原发性BCA(n = 5)和发育异常区域(n = 4)中进行了荧光原位杂交(FISH)。为了进行客观评估,使用了数字图像分析和激光扫描显微镜。六个BCA中的五个显示出明显的肿瘤内异质染色模式,范围从肿瘤细胞为阴性或微弱阳性的区域到整个膜均被强烈染色的肿瘤区域。在两个发育不良的区域中,还观察到异质染色模式。 FISH分析揭示了所有BCA中瘤内基因拷贝数变化的显着异质性,显示了具有多体性,低水平扩增和高水平扩增的不同分数细胞的群体。一个不典型增生显示少数人群具有Her-2 / neu信号簇。总之,我们在分析的大多数主要BCA中观察到了c-erbB-2蛋白过表达和Her-2 / neu基因拷贝数的明显肿瘤内异质性。数字图像分析和激光扫描显微镜有助于量化单个肿瘤细胞中蛋白质表达和DNA拷贝数的变化。观察到的异质性可能会妨碍小型活检中对c-erbB-2状态的准确诊断确定,并可能影响潜在的c-erbB-2靶向治疗的有效性。 http://www.esacp.org/acp/2000/20-1/walch.htm+ ++上的数字。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号